Green Sports Alliance Launches Strategy Playbook to Embed Sustainability into the Business of Sports
As billion-dollar stadiums rise and championship moments captivate the world, the climate crisis is quietly emerging as the industry's toughest opponent. The Strategy Playbook responds to this challenge with a clear message: sustainability isn't just the right thing to do—it's a smart business move.
"Every team owner, athlete, and entertainer has beaten the odds to reach the pinnacle of success," said Roger McClendon, Executive Director of Green Sports Alliance. "They are the A Team; they have the potential to increase revenue, mitigate risks, and provide leadership that results in a legacy of health and prosperity, not just for sport but for all of humanity."
The Strategy Playbook offers a framework—rather than a technical manual—for creating a sustainability strategy that drives measurable business value. Drawing on expertise from over 30 contributors and leading organizations.
This playbook was written in collaboration with the following Play to Zero members: 3R Sustainability, APTIM, CheckSammy, Delaware North, Keramida, Okapi Environmental Services, Populous, RWDI, Think Beyond, URT Solutions, and WM; along with the following corporate members: Agendi, D'Niche, Energy Sage, and TripleWin.
Strategy Playbook offers actionable insights for teams at every level—from collegiate to professional leagues. It includes case studies from Golden State Warriors, Denver Zoo, Hard Rock Stadium, Moody Center, Gillette Stadium, University of Illinois, Penn State University, Cincinnati Zoo, Cincinnati Reds, Florida Panthers, Chicago Cubs, FIFA, Austin FC, Saint Paul Arena Company, Ashton Gate Stadium, University of Wisconsin Stevens Point, and the Minnesota Twins.
Extreme weather, regulatory pressures, and shifting fan expectations have made the business case for sustainability. As McClendon puts it: "We're not just playing for today's wins; we're planning for tomorrow's future."
The Strategy Playbook is available at https://www.greensportsalliance.org/resources/playbooks
About Green Sports Alliance:The Green Sports Alliance leverages the cultural and market influence of sports and entertainment to promote healthy, sustainable communities where we live, work, and play.
The Green Sports Alliance convenes and educates professional and collegiate sports industries, the entertainment industry, and their partners to inspire environmental and social impact and to create a resilient and sustainable future for the next generation.
View original content:https://www.prnewswire.com/news-releases/green-sports-alliance-launches-strategy-playbook-to-embed-sustainability-into-the-business-of-sports-302479564.html
SOURCE Green Sports Alliance
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
4 hours ago
NJ says 3 chemical makers agree to 'forever chemical' settlement worth up to $2B
TRENTON, N.J. -- DuPont and two other companies will pay New Jersey up to $2 billion to settle environmental claims stemming from PFAS, commonly referred to as 'forever chemicals," the companies announced Monday. State Environmental Commissioner Shawn LaTourette said the deal with DuPont, Chemours and Corteva is the largest such settlement in the state's history. It calls for the companies to pay $875 million over 25 years and create a remediation fund of up $1.2 billion. The companies will split the costs under the deal, which must still be approved by the courts. PFAS, or perfluoroalkyl and polyfluoroalkyl substances, are a group of chemicals that have been around for decades and have now spread into the nation's air, water and soil. They are commonly referred to as 'forever chemicals.' DuPont said the settlement will resolve 'all pending environmental and other claims' for 'legacy" contamination claims at four sites where the companies operated in the state. It comes just months after the state said chemical manufacturer 3M has agreed to pay up $450 million to resolve lawsuits over natural resource contamination stemming from PFAS. "Polluters who place profit above public well-being by releasing poisonous PFAS and other contamination in our State can expect to be held responsible to clean up their mess and fully compensate the State and its citizens for the precious natural resources they've damaged or destroyed," LaTourette said. PFAS were manufactured by companies such as 3M, Chemours and others because they were incredibly useful. They helped eggs slide across non-stick frying pans, ensured that firefighting foam suffocates flames and helped clothes withstand rain and keep people dry. The chemicals resist breaking down, though, meaning they linger in the environment. Environmental activists say PFAS makers knew about the health harms of PFAS long before they were made public. The same attributes that make the chemicals so valuable – resistance to breakdown – make them hazardous to people. PFAS accumulate in the body, which is why the Environmental Protection Agency set their limits for drinking water at 4 parts per trillion for two common types — PFOA and PFOS — that are phased out of manufacturing but still are present in the environment.
Yahoo
6 hours ago
- Yahoo
Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million
NEW YORK, Aug 4, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the Brachytherapy Devices Market is witnessing significant growth due to the rising incidence of cancer worldwide and technological advancements in brachytherapy devices. The Brachytherapy Devices Market value is expected to reach US$534.20 million by 2031 from US$343.57 million in 2024; the market is anticipated to register a CAGR of 6.7% during 2025–2031. The market growth is attributed to the rising incidence of cancer worldwide, the aging population, and the technological advancements in brachytherapy devices. The Brachytherapy Devices Market analysis focuses on advancements such as MRI-compatible applicators and real-time imaging integration that play a vital role in the market growth. The report runs an in-depth analysis of market trends, key players, and future opportunities. Check valuable insights in the Brachytherapy Devices Market report. You can easily get a sample PDF of the report - Overview of Brachytherapy Devices Market Report Findings Rising Incidence of Cancer Worldwide:As per the GLOBOCAN 2020 report, more than 28.4 million new cancer cases are expected to be reported by 2040. An aging population, lack of physical activity, exposure to pollutants in the environment, and alterations in diet lead to increased rates of an internal radiation treatment, is ideal for the treatment of prostate, cervical, breast, and skin cancers. It allows for the radiation to be targeted directly to the tumor and avoid the surrounding healthy tissues, with reduced side effects and improved recovery times. Thus, brachytherapy is becoming increasingly popular among oncologists and cancer remains among the major causes of mortality globally, demand for effective, low-invasive, and affordable treatment procedures is rising. Brachytherapy is meeting this demand, particularly in facilities where it might not be possible to access highly advanced external radiation facilities. Thus, the increasing burden of cancers worldwide propels the market growth. Technological Advancements in Brachytherapy Devices:Advances in the area are improving the accuracy, safety, and effectiveness of treatments, making brachytherapy a progressively appealing choice for cancer technological advancements include the creation of high-dose rate (HDR) and low-dose rate (LDR) machines, which provide more accurate radiation delivery. HDR machines provide for administering higher doses of radiation in shorter times, making treatment faster and more convenient for patients. MRI-compatible applicators and integration of sophisticated imaging are providing better tumor localization and online monitoring of treatment. These advances allow clinicians to target tumors effectively with less exposure to healthy tissues in the proximity. The robot-assisted platforms provide higher accuracy and precision, particularly in challenging anatomical areas. In addition, miniaturization and mobility of brachytherapy equipment are facilitating treatments, especially in developing advances in technology are making brachytherapy more effective and safer but and increasing its uses in treating a broader spectrum of cancers. Consequently, the greater uptake of these machines is contributing to their adoption and setting the limits of cancer treatment even higher. Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific. Asia Pacific is expected to register the highest CAGR during the forecast period. Stay Updated on Brachytherapy Devices Market Trends: Brachytherapy Devices Market Segmentation Based on product, the Brachytherapy Devices Market is segmented into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders segment held the largest market share in 2024. In terms of type, the Brachytherapy Devices Market is categorized into high-dose rate brachytherapy implant and low-dose rate brachytherapy implant. The low-dose rate brachytherapy implant segment dominated the market in 2024. By application, the Brachytherapy Devices Market is segmented into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment dominated the market in 2024. Per end user, the Brachytherapy Devices Market is divided into hospitals and specialty clinics, ambulatory surgical centers, and others. The hospitals and specialty clinics segment dominated the market in 2024. The Brachytherapy Devices Market is segmented into five major regions: North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. Competitive Strategy and Development Key players: Elekta, Varian Medical Systems, Inc., BEBIG Medical, Theragenics Corporation, IsoAid, Siemens Healthineers AG, BXTA, BD, and Eckert and Ziegler are among the major companies operating in the Brachytherapy Devices Market. Trending topics: Advancements in Imaging Technologies, Government Initiatives and Cancer Treatment Programs, Technological Advancements in Brachytherapy Devices, Integration of Artificial Intelligence (AI) and Robotics in brachytherapy, etc. Headlines on Brachytherapy Devices Market Artemis Hospital Announces the Launch of Brachytherapy Services, Expanding Advanced Cancer Care Papua New Guinea Resumes Radiotherapy, Starts Brachytherapy Services with IAEA Support BEBIG Medical Launches SagiNova Brachytherapy System at Father Muller Hospital as a Part of New Healthcare Wing Medanta Patents MAOLO Brachytherapy Device For Advanced Cervical Cancer Treatment Elekta Expands Brachytherapy Portfolio With Acquisition of iCad Inc.'s Xoft Business CivaTech Oncology Receives FDA Approval for CivaSheet Brachytherapy Device Get Premium Copy of Brachytherapy Devices Market Size and Growth Report by 2031 at: Conclusion The growth of the Brachytherapy Devices Market is fueled by the increasing prevalence of cancer, advances in technology, and soaring demand for minimally invasive treatment options. The high-dose rate (HDR) systems, MRI-compatible applicators, and robotic-assisted devices are increasing the accuracy of treatment and speeding up patient recovery. Further, there is a growing demand for affordable and patient-centric therapies, particularly in areas that have poor access to conventional cancer therapy. With increasing uses in prostate, breast, and cervical cancers, the demand for brachytherapy is surging, with better results and accessibility in cancer therapy. The report from The Insight Partners provides several stakeholders—including manufacturers of seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy devices—with valuable insights to navigate this evolving market landscape and unlock new opportunities. Trending Related Reports: Brachytherapy After Loaders Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031 Cancer Therapy Market Scope, Share, and Size by 2031 Pancreatic Cancer Therapy Market SWOT Analysis by 2031 Lung Cancer Therapy Market Research Report by 2030 Cancer Biopsies Market Trends, Share, and Growth – 2031 Cervical Cancer Diagnostics and Therapeutics Market Size 2031 Kidney Cancer Therapeutics And Diagnostics Market Size 2031 Cancer Biopsies Market Trends, Share, and Growth - 2031 Thyroid Cancer Diagnostics Market Growth and Share by 2031 About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact Us:If you have any queries about this report or if you would like further information, please get in touch with us:Contact Person: Ankit MathurE-mail: +1-646-491-9876 Logo: View original content: SOURCE The Insight Partners Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
8 hours ago
- Yahoo
Javvy Coffee Launches Its Viral Protein Coffee at Select Target Stores Nationwide
LOS ANGELES, Aug. 4, 2025 /PRNewswire/ -- The internet's favorite brew, Javvy Coffee, is officially expanding to Target shelves nationwide! With the growing demand for healthier coffee alternatives, Javvy Coffee is stepping up with a better-for-you, protein-packed option that delivers on both taste and convenience. Starting August 3rd, Javvy Protein Coffee will be available in the coffee aisle at select Target locations and on With over 31,000 glowing Amazon reviews and a devoted online community, Javvy Coffee has clearly captured the hearts and taste buds of coffee lovers everywhere. Here's why it's become the go-to choice for so many: Energy you can feel good about: Enjoy 100% real coffee with 80mg of caffeine per scoop, without any bitter aftertaste. No added sugar. No artificial sweeteners. No stevia. Just bold flavor, real energy, and zero weirdness. Premium Whey Protein: Each serving delivers 10g of premium whey protein (that's 20g per 2 scoops)—perfect for mornings, workouts, or anytime you need an energy + protein boost. Affordably Priced: Javvy costs less than store-bought brews and coffee shops—delivering quality that doesn't break the bank. Target will carry Javvy Protein Coffee in three delicious flavors: Caramel, French Vanilla, and Original, priced at $24.99. Each serving blends the rich flavor of 100% real coffee with premium whey protein for a guilt-free indulgence. Packed with 10g of protein, no added sugar, prebiotics for gut health, and brain-boosting MCTs, Javvy Protein Coffee is perfect for satisfying your coffee cravings while supporting your health and wellness goals. "Target guests want feel-good choices that don't sacrifice convenience or taste, especially when it comes to their daily coffee routine. That's why landing at Target is such a meaningful step for us," says Brandon Monaghan, Co-Founder and CMO of Javvy Coffee. "Javvy puts a guilt-free protein rich boost right within reach, no compromise required. We're excited to meet shoppers where they are with a functional coffee they'll genuinely enjoy every single day." About Javvy Coffee: Loved for its smooth taste, real ingredients, and unmatched convenience, Javvy Coffee is revolutionizing the way we enjoy coffee—quickly becoming a household name for those who demand convenience without compromising the taste or quality. Discover the full selection at To find Javvy Coffee at your nearest Target location, visit For all Press Inquiries contact:Morgan Publicity399082@ View original content to download multimedia: SOURCE Javvy Coffee Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
